Bio-Rad Reports Third-Quarter 2021 Financial Results.

Q3 NON-GAAP EARNINGS PER SHARE $3.71.
Q3 SALES ROSE 15.4 PERCENT TO $747 MILLION.
BIO RAD LABORATORIES - NOW ANTICIPATES 2021 NON-GAAP CURRENCY-NEUTRAL REVENUE GROWTH BETWEEN 12 TO 13 PERCENT.
SEES 2021 ESTIMATED NON-GAAP OPERATING MARGIN OF ABOUT 19.5 PERCENT.
QTRLY GAAP INCOME PER SHARE $129.96.